Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Ferroportin inhibition attenuates pulmonary hypertension in hypoxic sickle cell disease mice.
Journal: Blood advances
Published: October 07, 2025
Ferroportin Inhibition Attenuates Pulmonary Hypertension in Hypoxic Sickle Cell Disease Mice.
Journal: Blood advances
Published: October 07, 2025
Combined haptoglobin and hemopexin therapy for the treatment of cardiopulmonary dysfunction in sickle cell disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 30, 2025
Metabolic and Proteomic Divergence is Present in Spleens and Livers from Berkeley Sickle Cell Anemia and β-Thalassemia Mice.
Journal: Journal of proteome research
Published: February 13, 2025
Targeting lung heme iron by aerosol hemopexin adminstration in sickle cell disease pulmonary hypertension.
Journal: Free radical biology & medicine
Published: December 01, 2024
Showing 1-5 of 5
Last Updated: 09/26/2026